Gamma Biosciences

Enabling the Promise of Advanced Therapies

Menlo Park, United States · Founded 2019

Employees
11–50
Founded
2019
Business Model
B2B

About

Gamma Biosciences is a life sciences tools platform created by KKR with a mission to build a leading player in next-generation bioprocessing for advanced therapies including cell therapy, gene therapy, vaccines, and viral vector manufacturing. The company pursues this mission by acquiring and investing in high-potential businesses with outstanding bioprocessing technology and accelerating their growth, having backed companies such as Astrea Bioseparations, Mirus Bio, Univercells Technologies, and Nanopareil. Founded in 2019 and headquartered in Menlo Park, California, Gamma Biosciences raised million in private equity and operates as a partnership under the KKR umbrella.

Summary

Gamma Biosciences is a Biotech company based in Menlo Park, United States, founded in 2019.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Gamma Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/gamma-biosciences"><img src="https://indexed.vc/api/badge/company/gamma-biosciences" alt="Gamma Biosciences on Indexed.vc" width="260" height="76" /></a>